Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients

Transplant Proc. 1997 Feb-Mar;29(1-2):784-6. doi: 10.1016/s0041-1345(96)00101-7.
No abstract available

MeSH terms

  • Adult
  • Alanine Transaminase / blood
  • Follow-Up Studies
  • Genotype
  • Hepacivirus / genetics
  • Hepacivirus / isolation & purification
  • Hepatitis C / diagnosis
  • Hepatitis C / therapy*
  • Humans
  • Interferon Type I / therapeutic use*
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Postoperative Complications*
  • RNA, Viral / blood
  • Recombinant Proteins
  • Time Factors
  • Transplantation, Homologous

Substances

  • Interferon Type I
  • RNA, Viral
  • Recombinant Proteins
  • Alanine Transaminase